Medical ceramics market to $2.2 billion in 2021

Medical ceramics market to $2.2 billion in 2021

n-tech projects that revenues from ceramics used in regenerative medicine will reach $313M by 2021, reaching more than $500M by 2025.

April 8, 2016

Glen Allen, Virginia – According to a new report from industry analyst firm n-tech Research, the global market for medical ceramic will grow to around $2.2 billion in revenue in 2021. The report titled, "Worldwide Medical Ceramic Markets 2016-2025," identifies the current and future opportunities in the medical ceramics space and provides guidance on the technical and regulatory framework in which these opportunities are arising.

This report analyzes the market for medical ceramics, a business that n-tech believes will major opportunity for both materials firms and medical device manufacturers in the coming decade. It examines the latest products, with a special focus on product releases in the past year, as well as the recent technical developments in the medical ceramics space. It also discusses the hurdles that medical ceramic products must overcome to achieve market acceptance, including the demands made by regulatory regimes in leading national and regional markets.

Medical ceramics is already established for orthopedic and dental implants; areas in which they provide patients with metals-free solutions. This report shows how the revenue generation for medical ceramics can be extended to newer areas such the as healing of long segmental bone defects and to scaffold-guided bone replacements.

This report also provides n-tech's assessments of the strategies of leading firms active in medical and dental ceramics space. In addition, the report contains granular ten-year forecasts of medical/dental ceramic shipments in volume and value terms, with breakouts by application, type of material and geographical region. 

Materials covered include alumina, zirconia, silicon ceramics, hydroxyapatite, bioglass, piezoceramics, nanoceramics, and other materials. Applications discussed in this report include, hip and knee implants; crowns, bridges and other dental implants; surgical and diagnostic tools, implantable electronic implants, and regenerative medicine. Ceramics are an ideal material in these applications because of their wear resistance, inherent stability and excellent electrical properties.

Major firms that are discussed in the report include: 3M, Advanced BioHealing, Amedica Bioengineering Laboratories, Bonesupport, CeramTec, CoorsTek Medical, Cytophil, Danaher, Dentsply-Sirona, DiscGenics, RegenScientific, DePuy Synthes, Heraeus Johnson & Johnson, Kinetic Concepts, MicroPort Orthopedics, Morgan Technical Ceramics, Straumann, Stryker, and Zimmer Biomet.

From the report
Since n-tech's first report on medical ceramics in 2013, the medical community has become even more skeptical of with regard to the long-term performance and biocompatibility of metallic implants. As a result, we are continuing to see a major shift to ceramic implants. By 2021, the total value of ceramics used in implants will have reached $1.7 billion, going on to reach $2.6 billion by 2025.

Meanwhile, n-tech projects that revenues from ceramics used in regenerative medicine will reach $313 million by 2021 going on to reach more than $500 million by 2025. Of particular importance here is the rise of scaffold-guided tissue engineering for which ceramics is ideal because of its biocompatibility. n-tech also believes that ceramic powders using alumina and zirconia will be extensively used in the bone reconstruction market.

Although the medical ceramics business will be dominated by alumina, zirconia and hydroxyapatite, other materials are on the rise. For example, bioglass is expected to reach almost $240 million in sales by 2021, compared with around $120 million today. 

Source: n-tech